Qube Research & Technologies (QRT)
CRBP icon

Qube Research & Technologies (QRT)’s Corbus Pharmaceuticals CRBP Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$173K Buy
18,476
+2,562
+16% +$21.6K ﹤0.01% 2987
2025
Q4 		$130K Buy
+15,914
New +$196K ﹤0.01% 3141
2024
Q4 		– Sell
-15,321
Closed -$316K – 3504
2024
Q3 		$316K Buy
15,321
+14,575
+1,954% +$746K ﹤0.01% 2409
2024
Q2 		$33.8K Sell
746
-8,906
-92% -$375K ﹤0.01% 2806
2024
Q1 		$379K Buy
+9,652
New +$238K ﹤0.01% 2688
2021
Q4 		– Sell
-415
Closed -$13K – 2587
2021
Q3 		$13K Buy
+415
New +$16.4K ﹤0.01% 2015

Other funds holding CRBP

CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
DP
Diadema Partners Morristown, New Jersey $588M AUM 182.75% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Qube Research & Technologies (QRT)'s CRBP Position: Q1 2026 in Review

Qube Research & Technologies (QRT) increased its Corbus Pharmaceuticals (CRBP) stake by 16% in Q1 2026, buying an estimated $21.6K and bringing the position to 18,476 shares worth $173K. The position accounts for ﹤0.01% of the portfolio, ranked #2987.

Qube Research & Technologies (QRT) first reported a position in CRBP in Q3 2021 and has held it in 6 quarters since. The position peaked at $379K in Q1 2024. 107 funds tracked by Wall St. Rank hold CRBP as of Q1 2026.

  • Qube Research & Technologies (QRT) held 18,476 shares of Corbus Pharmaceuticals worth $173K as of Q1 2026.
  • Qube Research & Technologies (QRT) bought 2,562 Corbus Pharmaceuticals shares in Q1 2026, an estimated $21.6K.
  • Corbus Pharmaceuticals made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #2987 holding.
  • Qube Research & Technologies (QRT) first reported a position in Corbus Pharmaceuticals in Q3 2021 and has held it in 6 quarters since.
  • Qube Research & Technologies (QRT)'s Corbus Pharmaceuticals position peaked at $379K in Q1 2024.
  • 107 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.